RDHL
$0.88
Pre-MarketAs of Mar 17, 8:00 PM UTC
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases.
Historical Price
Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$0.88
Potential Downside
100%
Whystock Fair Value$0.00
Price
UndervaluedFair ValueOvervalued
Fundamentals
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the trea...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.47M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
4.99
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.37
Recent News
Sector Update: Health Care Stocks Rise in Late Afternoon Trading
Health care stocks advanced late Tuesday afternoon, with the NYSE Health Care Index and the Health C
Surrey loses rush-hour taxis to thousands of school runs
Workers in Surrey have been left unable to book a taxi first thing in the morning because firms are too busy ferrying pupils to state schools.